Clinical Trial

Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment Resistant Schizophrenia

Study acronym: TRACE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Cognitive impairment is a major determinant of disability in schizophrenia. Aerobic exercise improves global cognition in schizophrenia, particularly working memory and attention/vigilance. Transcranial direct current stimulation (tDCS) targeting frontal regions has shown promise for cognitive deficits, including working memory improvements in some studies. This randomized 2×2 factorial trial will test the independent and combined effects of supervised aerobic exercise and prefrontal tDCS on cognition in treatment resistant schizophrenia, measured using the MATRICS Consensus Cognitive Battery (MCCB).
Trial Details
NCT Number NCT07404319
Lead Sponsor Kit Wa Chan
Conditions Schizophrenia, Treatment Resistant Schizophrenia, Cognitive Impairment
Enrollment 160 participants
Start Date 2026-02-23
Primary Completion 2028-01-30 (estimated)
Study Completion 2028-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-11